Disclosures for "An Assessment of Acute Pharmacodynamic Drug-drug Interactions (PD-DDIs) Between Cannabidiol (CBD) and Cenobamate (CNB) in a Mouse Model of Generalized Tonic Seizures"
-
Dr. Rana has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
-
Dr. Hind has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Hind has stock in Jazz Pharmaceuticals. Dr. Hind has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Patra has nothing to disclose.
-
Saga Johansson has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Saga Johansson has stock in Jazz pharmaceuticals.
-
Dr. Rajasekaran has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
-
Prof. White has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Prof. White has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharm. The institution of Prof. White has received research support from NIH. The institution of Prof. White has received research support from Neurelis.
-
Dr. Virley has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Dr. Virley has stock in Jazz Pharmaceuticals . Dr. Virley has received intellectual property interests from a discovery or technology relating to health care.